Synta Pharmaceuticals(SNTA)

xlfrog2014-03-25 23:42

$Synta Pharmaceuticals(SNTA)$ 潜在非常好的药物，几乎烂在前高管手里，偶联药物也挺有前景的，现在感觉是缺钱查看全文

xlfrog2014-03-25 00:50

$Synta Pharmaceuticals(SNTA)$ 向下到4的支撑？查看全文

菜鸟闷声发大财2014-03-20 21:13

$Synta Pharmaceuticals(SNTA)$ 再来把7块吧!!哈哈查看全文

xlfrog2014-03-19 20:33

$Synta Pharmaceuticals(SNTA)$ 有人抬轿子？查看全文

xlfrog2014-03-14 00:38

$Synta Pharmaceuticals(SNTA)$ 这是向under 4 走？查看全文

xlfrog2014-03-12 22:58

$Synta Pharmaceuticals(SNTA)$ 从一段时间观察看，Galaxy2 trial失败的可能性在CC和CEO开掉之后显著增大！除了卖掉，看不到有利前景。看多的，慎重！已有评论公司没有设计好Trial，同意！浪费了HSP90的机会，可惜查看全文

xlfrog2014-03-12 20:26

$Synta Pharmaceuticals(SNTA)$ 看来有人和我的感觉类似。Stifel downgrades Synta Pharmaceuticals (SNTA) from Hold to Sell.
Analyst Brian Klein cites delayed data readouts, changes in clinical trial designs, management changes and the need for additional capital as reasons for...查看全文

xlfrog2014-03-12 01:10

$Synta Pharmaceuticals(SNTA)$ CC 听完了，公司气氛不好查看全文

xlfrog2014-03-11 22:05

$Synta Pharmaceuticals(SNTA)$ 其它非Galaxy trials 这个阶段都是忽悠查看全文

xlfrog2014-03-11 22:04

$Synta Pharmaceuticals(SNTA)$ 钱够烧到今年年底[好失望]。Galaxy2中期结果要等到明年下半年，最终结果2016。没有人收购或者再融资，悬了！东西很有潜力，时间不够呀查看全文

$Synta Pharmaceuticals(SNTA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-07 AccNo: 0001104659-18-049982 Size: 3 MB 网页链接

$Synta Pharmaceuticals(SNTA)$ S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers Filed: 2018-06-05 AccNo: 0001047469-18-004269 Size: 597 KB 网页链接

$Synta Pharmaceuticals(SNTA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-04-27 AccNo: 0001104659-18-027846 Size: 128 KB 网页链接

$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-27 AccNo: 0001140361-18-020147 Size: 551 KB 网页链接

$Synta Pharmaceuticals(SNTA)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001140361-18-020146 Size: 4 MB 网页链接

$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-27 AccNo: 0001140361-18-020147 Size: 551 KB 网页链接

$Synta Pharmaceuticals(SNTA)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001140361-18-020146 Size: 4 MB 网页链接

$Synta Pharmaceuticals(SNTA)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-13 AccNo: 0001047469-18-001557 Size: 5 MB 网页链接

$Synta Pharmaceuticals(SNTA)$ 8-K - Current report Filed: 2017-12-21 AccNo: 0001104659-17-074616 Size: 287 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Synta Pharmaceuticals(SNTA)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-12-18 AccNo: 0001047469-17-007712 Size: 1 MB 网页链接